Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
NDBKY Quote, Financials, Valuation and Earnings
Last price:
$13.64
Seasonality move
:
1.13%
Day range:
$13.48 - $13.63
52-week range:
$11.75 - $18.13
Dividend yield:
8.27%
P/E ratio:
7.16x
P/S ratio:
1.74x
P/B ratio:
0.96x
Volume:
17.9K
Avg. volume:
10.8K
1-year change:
-5.25%
Market cap:
$6.4B
Revenue:
$3.7B
EPS (TTM):
$1.93
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $3.6B | $3.6B | $3.5B | $3.7B | |
| Revenue Growth (YoY) | -14.74% | 17.74% | -0.39% | -2.36% | 4.97% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $81.4M | $110.3M | $112.5M | $103.3M | $107M | |
| Other Inc / (Exp) | -$91M | $24.7M | $43.2M | $53.4M | $52.9M | |
| Operating Expenses | $1.8B | $2.1B | $2B | $1.9B | $2.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $386.8M | $1.1B | $1.2B | $1.2B | $1.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $114.7M | $273.5M | $265.1M | $239.7M | $258.8M | |
| Net Income to Company | $386.8M | $1.1B | $1.2B | $1.2B | $1.3B | |
| Minority Interest in Earnings | -$3.4M | -$6.7M | -$10M | -$13.1M | -$8.2M | |
| Net Income to Common Excl Extra Items | $268.8M | $831.2M | $934.7M | $906.4M | $999M | |
| Basic EPS (Cont. Ops) | $0.44 | $1.57 | $1.80 | $1.75 | $1.97 | |
| Diluted EPS (Cont. Ops) | $0.43 | $1.54 | $1.75 | $1.69 | $1.92 | |
| Weighted Average Basic Share | $483.2M | $485.1M | $486.9M | $472.5M | $466.4M | |
| Weighted Average Diluted Share | $488.7M | $494.8M | $500.7M | $472.5M | $466.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.1B | $3.4B | $4.1B | $5.3B | $5.8B | |
| Revenue (Reported) | $3.1B | $3.6B | $3.6B | $3.5B | $3.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.1B | $3.4B | $4.1B | $5.3B | $5.8B | |
| Period Ending | 2009-12-31 | 2010-12-31 | 2011-12-31 | 2012-12-31 | 2013-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.9B | $1.9B | $2B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | 19.19% | 2.67% | -4.94% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $188.6M | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.1B | $1.4B | $1.3B | $1.3B | $1.1B | |
| Operating Income | $432.1M | $544.9M | $582.9M | $662M | $616.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $432.1M | $545.1M | $582.9M | $662.2M | $619.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $80.8M | $119.2M | $143.4M | $173.1M | $152.4M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$1.9M | -$15.8M | -$19.4M | -$21.4M | -$17.4M | |
| Net Income to Common Excl Extra Items | $351.3M | $425.9M | $420.2M | $467.9M | $449.4M | |
| Basic EPS (Cont. Ops) | $0.71 | $0.90 | $0.92 | $191.62 | $177.65 | |
| Diluted EPS (Cont. Ops) | $0.68 | $0.87 | $0.91 | $185.87 | $172.44 | |
| Weighted Average Basic Share | $432.9M | $447.1M | -- | -- | -- | |
| Weighted Average Diluted Share | $450.6M | $462.8M | -- | -- | -- | |
| EBITDA | $432.1M | $544.9M | $502M | $662M | $616.7M | |
| EBIT | $2.4B | $2.6B | $2.1B | $2.1B | $1.8B | |
| Revenue (Reported) | $1.6B | $1.9B | $1.9B | $2B | $1.8B | |
| Operating Income (Reported) | $432.1M | $544.9M | $582.9M | $662M | $616.7M | |
| Operating Income (Adjusted) | $2.4B | $2.6B | $2.1B | $2.1B | $1.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $3.6B | $3.6B | $3.5B | $3.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$96.4M | $21.3M | $43.8M | $52.7M | $52.5M | |
| Operating Expenses | $1.7B | $2.1B | $2B | $1.9B | $2.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $382.6M | $1.1B | $1.2B | $1.1B | $1.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $112.7M | $273.3M | $261.6M | $236.5M | $260.5M | |
| Net Income to Company | $383.4M | $1.1B | $1.2B | $1.1B | $1.3B | |
| Minority Interest in Earnings | -$3.1M | -$6.6M | -$9.9M | -$13M | -$8.3M | |
| Net Income to Common Excl Extra Items | $266.8M | $830.3M | $919.2M | $894.1M | $1B | |
| Basic EPS (Cont. Ops) | $0.44 | $1.57 | $1.77 | $1.73 | $1.98 | |
| Diluted EPS (Cont. Ops) | $0.43 | $1.53 | $1.72 | $1.67 | $1.93 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | $3B | $3.6B | $3.6B | $3.5B | $3.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2021-07-17 | 2022-07-17 | 2023-07-17 | 2024-07-17 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.8B | $2.8B | $4B | $3.9B | $4.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $8.3B | $5.3B | $6.6B | $6.1B | $6.8B | |
| Property Plant And Equipment | $773.7M | $672.5M | $649.4M | $586.8M | $751.6M | |
| Long-Term Investments | $20.1B | $17.4B | $15.2B | $16.2B | $17.6B | |
| Goodwill | -- | -- | $251.9M | $215.7M | $213.3M | |
| Other Intangibles | -- | -- | $490.5M | $428.3M | $459.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $83.6B | $76.1B | $73.5B | $70.5B | $75.4B | |
| Accounts Payable | -- | -- | $539.8M | $678.5M | $675.5M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $40.3M | $20.7M | $558.7M | $695.4M | $692.7M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $76.7B | $69.2B | $66.7B | $64.1B | $68.7B | |
| Common Stock | $249M | $34.1M | $33M | $31.9M | $31.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $6.6B | $6.8B | $6.8B | $6.4B | $6.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $31.8M | $38.8M | $41M | $47.7M | $49M | |
| Total Equity | $6.9B | $6.9B | $6.8B | $6.4B | $6.7B | |
| Total Liabilities and Equity | $83.6B | $76.1B | $73.5B | $70.5B | $75.4B | |
| Cash and Short Terms | $2.8B | $2.8B | $4B | $3.9B | $4.1B | |
| Total Debt | $4.1B | $3.6B | $3.2B | $2.7B | $2.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.8B | $2.8B | $4B | $3.9B | $4.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $8.3B | $5.3B | $6.6B | $6.1B | $6.8B | |
| Property Plant And Equipment | $773.7M | $672.5M | $649.4M | $586.8M | $751.6M | |
| Long-Term Investments | $20.1B | $17.4B | $15.2B | $16.2B | $17.6B | |
| Goodwill | -- | -- | $251.9M | $215.7M | $213.3M | |
| Other Intangibles | -- | -- | $490.5M | $428.3M | $459.6M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $83.6B | $76.1B | $73.5B | $70.5B | $75.4B | |
| Accounts Payable | -- | -- | $539.8M | $678.5M | $675.5M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $40.3M | $20.7M | $558.7M | $695.4M | $692.7M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $76.7B | $69.2B | $66.7B | $64.1B | $68.7B | |
| Common Stock | $249M | $34.1M | $33M | $31.9M | $31.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $31.8M | $38.8M | $41M | $47.7M | $49M | |
| Total Equity | $6.9B | $6.9B | $6.8B | $6.4B | $6.7B | |
| Total Liabilities and Equity | $83.6B | $76.1B | $73.5B | $70.5B | $75.4B | |
| Cash and Short Terms | $2.8B | $2.8B | $4B | $3.9B | $4.1B | |
| Total Debt | $4.1B | $3.6B | $3.2B | $2.7B | $2.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $386.8M | $1.1B | $1.2B | $1.2B | $1.3B | |
| Depreciation & Amoritzation | $239.9M | -- | $250.3M | $223.1M | $241.5M | |
| Stock-Based Compensation | $16.5M | -- | $54.1M | $54.9M | $40.7M | |
| Change in Accounts Receivable | -$96.5M | $51M | $119.7M | $101.2M | $10.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $814.6M | $821.1M | $1.2B | $1.6B | $1B | |
| Capital Expenditures | $263.5M | $233.7M | $194.5M | $209.4M | $252.1M | |
| Cash Acquisitions | $9.9M | -$2.9M | $20.8M | -- | -$85.3M | |
| Cash From Investing | -$294.3M | -$138.7M | -$160.8M | -$194.1M | -$300.1M | |
| Dividends Paid (Ex Special Dividend) | -$229.2M | -$160.6M | -$486.2M | -$472M | -$541.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $439.3M | $445M | $87.2M | $261.9M | $686.3M | |
| Long-Term Debt Repaid | -$430.1M | -$557.7M | -$478.3M | -$490.9M | -$652.6M | |
| Repurchase of Common Stock | -- | -$212.7M | -- | -$272.8M | -$90.4M | |
| Other Financing Activities | $5.9M | $101.3M | $55.1M | $13.5M | $127M | |
| Cash From Financing | -$292.5M | -$501.4M | -$933M | -$1.1B | -$593.3M | |
| Beginning Cash (CF) | $2.3B | $2.8B | $2.7B | $2.5B | $2.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $227.8M | $181.1M | $60.7M | $333.2M | $132.3M | |
| Ending Cash (CF) | $2.5B | $3B | $2.8B | $2.8B | $3B | |
| Levered Free Cash Flow | $551.1M | $587.4M | $960M | $1.4B | $773.6M | |
| Period Ending | 2009-06-30 | 2010-06-30 | 2011-06-30 | 2012-06-30 | 2013-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $157.6M | -$420.6M | $729.2M | $244.1M | $857.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$49.2M | -$319.9M | -$314.6M | -$256.8M | -$175.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$70.5M | $866.4M | $122.1M | -$132.9M | -$564.2M | |
| Beginning Cash (CF) | $2.4B | $2.4B | $2.9B | $3B | $2.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -$1.6M | $4.3M | -$4.5M | |
| Additions / Reductions | $37.9M | $126M | $535.1M | -$141.2M | $113.8M | |
| Ending Cash (CF) | $2.4B | $2.5B | $3.4B | $2.9B | $2.8B | |
| Levered Free Cash Flow | $157.6M | -$420.6M | $729.2M | $244.1M | $857.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $383.4M | $1.1B | $1.2B | $1.1B | $1.3B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$18.2M | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $794.2M | $776M | $1.1B | $1.6B | $1B | |
| Capital Expenditures | $258.3M | $232.2M | $190.2M | $206.5M | $254.4M | |
| Cash Acquisitions | $10.4M | -$2.6M | $21.5M | -- | -$85.3M | |
| Cash From Investing | -$284.7M | -$134.5M | -$160.1M | -$191.4M | -$304.2M | |
| Dividends Paid (Ex Special Dividend) | -$207.1M | -$154.3M | -$479M | -$465.6M | -$543.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $417.9M | $453.9M | -- | $258.4M | $693.5M | |
| Long-Term Debt Repaid | -$429.5M | -$565.5M | -$479.6M | -$484.3M | -$652.1M | |
| Repurchase of Common Stock | -- | -- | -- | -$269.3M | -$92.5M | |
| Other Financing Activities | $13.4M | $102.6M | $58.4M | $13.4M | $131.3M | |
| Cash From Financing | -$280.7M | -$484.4M | -$928.6M | -$1.1B | -$586.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $258.9M | $199.4M | $66.5M | $320.7M | $186.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $535.9M | $543.8M | $954.3M | $1.4B | $785M | |
| Period Ending | 2021-07-17 | 2022-07-17 | 2023-07-17 | 2024-07-17 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get NDBKY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NDBKY
Sector
P/E ratio
7.16x
12.18x
PEG ratio
0.58x
0.40x
P/B ratio
0.96x
1.10x
Price / LTM sales
1.74x
2.66x
Growth Metrics
NDBKY
Sector
Revenue growth
--
5.1%
Earnings growth
--
2.61%
Revenue (5-year growth)
0.49%
5.17%
Earnings forecast
--
$0.61
Profitability
NDBKY
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
11.06%
5.2%
Return on assets
1.38%
0.97%
Return on equity
15.53%
9.24%
Earnings Date
Last Earnings Date
Feb
28
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Oct
16
Balance Sheet
NDBKY
Sector
Total cash
$4.1B
$452M
Short term investments
--
$220.9M
Total assets
$75.4B
$3.8B
Long term debt
$2.8B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
